DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Tivantinib is an investigational drug.
There have been 27 clinical trials for Tivantinib. The most recent clinical trial was a Phase 2 trial, which was initiated on November 1st 2010.
The most common disease conditions in clinical trials are Carcinoma, Lung Neoplasms, and Carcinoma, Hepatocellular. The leading clinical trial sponsors are National Cancer Institute (NCI), Daiichi Sankyo Inc., and ArQule.
Recent Clinical Trials for Tivantinib
|TIvantinib as Maintenance Treatment in Extended Small-cell Lung Cancer (TIMES)||Istituto Oncologico Veneto IRCCS||Phase 2|
|Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment||Medpace, Inc.||Phase 1|
|Pharmacokinetics of Tivantinib in Subjects With Advanced Solid Tumors and Hepatic Impairment||Daiichi Sankyo Inc.||Phase 1|